SCHEMBL8943531

SCHEMBL8943531

COc1ccccc1N1CCN(CC(O)C(C)(C)C)CC1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 4/20 0.66
ALDH1A1 P00352 3/20 0.66
KDM4E B2RXH2 3/20 0.66
CYP1A2 P05177 2/20 0.66
CYP3A4 P08684 2/20 0.66
CYP2D6 P10635 2/20 0.66
ALOX15 P16050 2/20 0.66
HSD17B10 Q99714 1/20 0.66
RECQL P46063 1/20 0.64
IGF1R P08069 1/20 0.62
MAPT P10636 6/20 0.61
DRD2 P14416 3/20 0.58
LMNA P02545 4/20 0.58
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
MAPK1 P28482 2/20 0.58
TDP1 Q9NUW8 2/20 0.58
KCNH2 Q12809 2/20 0.58
TP53 P04637 2/20 0.58
HIF1A Q16665 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30547268 0.85 RECQL (0.68) HTR1AALDH1A1KDM4ECYP1A2CYP3A4
SCHEMBL11626341 0.85 RECQL (0.68) HTR1AALDH1A1KDM4ECYP1A2CYP3A4
SCHEMBL10532593 0.83 RECQL (0.67) HTR1AALDH1A1KDM4ECYP1A2CYP3A4
SCHEMBL13875130 0.82 RECQL (0.73) HTR1AALDH1A1KDM4ECYP1A2CYP3A4
SCHEMBL12781836 0.82 RECQL (0.73) HTR1AALDH1A1KDM4ECYP1A2CYP3A4
SCHEMBL12304200 0.81 DRD2 (0.66) HTR1AALDH1A1KDM4ERECQLIGF1R
SCHEMBL8442587 0.81 IGF1R (0.81) HTR1AALDH1A1KDM4ECYP1A2CYP3A4
SCHEMBL8483863 0.81 RECQL (0.71) HTR1AALDH1A1KDM4ECYP1A2CYP3A4
SCHEMBL8483868 0.81 RECQL (0.71) HTR1AALDH1A1KDM4ECYP1A2CYP3A4
SCHEMBL7291084 0.81 RECQL (0.71) HTR1AALDH1A1KDM4ECYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5541326-A PHARMACEUTICAL COMPOSITION USED TO TREAT CENTRAL NERVOUS SYSTEM DISORDERS JOHN WYETH & BROTHER, LIMITED (GB) 1996-07-30 US disclosed
US-5420278-A ω-(4-aryl or heteroarylpiperazine-1-yl)-2-aryl or aralkyl-propanoic or butanoic acids JOHN WYETH & BROTHER, LIMITED (GB) 1995-05-30 US disclosed
US-5382583-A Hydroxytryptamine antagonists JOHN WYETH & BROTHER, LIMITED (GB) 1995-01-17 US disclosed
US-5364849-A Treatment of anxiety JOHN WYETH & BROTHER, LIMITED (GB) 1994-11-15 US disclosed
US-5340812-A Antiserotonin. anxiolytic agents JOHN WYETH & BROTHER, LIMITED (GB) 1994-08-23 US disclosed
EP-0395312-A2 Piperazine derivatives JOHN WYETH & BROTHER LIMITED (GB) 1990-10-31 EP disclosed